Possible autoimmune hemolytic anemia induced by secukinumab: a case report

Secukinumab, an anti-IL-17 monoclonal antibody, has been used to treat psoriasis and psoriatic arthritis since 2015. Several adverse events were reported, such as diarrhea, upper respiratory tract infection, middle ear infection, and neutropenia. Here we report a probable case of autoimmune hemolyti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Perdana Aditya, Kalim, Handono, Prawitasari, Suci, Raharjo, Fajar Maulana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917466/
https://www.ncbi.nlm.nih.gov/pubmed/35317476
http://dx.doi.org/10.11604/pamj.2022.41.41.32191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917466/
https://www.ncbi.nlm.nih.gov/pubmed/35317476
http://dx.doi.org/10.11604/pamj.2022.41.41.32191

Ejemplares similares